| Conferences \ BioProcessing, Biologics & Biotherapeutics Congress \ Antibody and Peptide Therapeutics \ Agenda \ Ralf Lutterbuese |
| Register | Login |
Recruiting T Cells for Cancer Therapy by BiTE Antibodies in Clinical TrialsWednesday, 20 July 2011 at 10:00  Add to Calendar ▼2011-07-20 10:00:002011-07-20 11:00:00Europe/LondonRecruiting T Cells for Cancer Therapy by BiTE Antibodies in Clinical TrialsSELECTBIOenquiries@selectbiosciences.comBiTE antibodies are single-chain bispecific antibodies directing cytotoxic T cells to target-expressing cancer cells, leading to highly efficient lysis of target cells. CD19-specific Blinatumomab has shown very high response rates in NHL and ALL patients in phase 1 and 2. |
Add to Calendar ▼2011-07-20 00:00:002011-07-21 00:00:00Europe/LondonAntibody and Peptide TherapeuticsSELECTBIOenquiries@selectbiosciences.com
